Cellivery has ranked among the top searched stocks on 4 days in the past month.

As of 2:32 PM on the 18th, Cellivery is trading at 142,300 KRW, up 3.57% from the previous day. This marks a 45.2% increase compared to July 20.

Today, foreigners are tentatively recorded as net sellers of 9,000 shares. Over the past 5 days, individual investors have net sold 13,194 shares, while foreigners and institutions have net bought 20,721 shares and 4,734 shares respectively.

On August 13, Cellivery made headlines in the market with the announcement, "Producing capsule-type obesity treatment to compete with Saxenda, a 1 trillion KRW sales obesity drug..."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing